RXDX
Allianz Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,200
| Closed | -$1.31M | – | 1779 |
|
|
2023
Q1 | $1.31M | Buy |
12,200
+700
| +6% | +$75.1K | ﹤0.01% | 1174 |
|
|
2022
Q4 | $1.27M | Hold |
11,500
| – | – | ﹤0.01% | 1160 |
|
|
2022
Q3 | $679K | Sell |
11,500
-49,633
| -81% | -$2.93M | ﹤0.01% | 1273 |
|
|
2022
Q2 | $1.73M | Buy |
61,133
+27,998
| +84% | +$790K | ﹤0.01% | 1335 |
|
|
2022
Q1 | $1.25M | Buy |
33,135
+22,065
| +199% | +$833K | ﹤0.01% | 1495 |
|
|
2021
Q4 | $438K | Buy |
+11,070
| New | +$438K | ﹤0.01% | 1865 |
|